Zhejiang Xianju Pharmaceutical Co.,Ltd. (002332.SZ) has a MoatMap StockRank of 84/100 based on Quality (67/100), Value (56/100), and Momentum (46/100) factor scores. The current signal is STRONG BUY. Zhejiang Xianju Pharmaceutical is primarily a domestic Chinese manufacturer of active pharmaceutical ingredients and steroid hormones. It lacks the global scale, high-utilization CDMO pricing power, and regulatory moat of our target CDMO theme beneficiaries.
Zhejiang Xianju Pharmaceutical Co., Ltd. specializes in the research, development, and manufacture of steroid hormone drugs, including cortical hormones, sex hormones, and progesterone. The company holds a dominant market position in China, supported by a vertically integrated value chain from active pharmaceutical ingredients (APIs) to finished formulations and international FDA/GMP certifications. It operates as a high-barrier, specialized pharmaceutical leader with a strong global export footprint.
| Price | $1.26 |
| Market Cap | $1.2B |
| P/E (TTM) | 20.85 |
| P/E (Forward) | 9.81 |
| Price/Book | 1.36 |
| Return on Equity | 6.6% |
| Return on Invested Capital | 8.7% |
| Debt/Equity | 2.42 |
| Gross Margin | 61.3% |
| Operating Margin | 12.3% |
| Revenue Growth | -8.9% |
| Dividend Yield | 3.6% |
| Free Cash Flow | $6M |
Zhejiang Xianju Pharmaceutical Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).